|
Volumn 30, Issue 7, 2014, Pages 582-589
|
Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment
a a a a a
a
Profil Mainz
(Germany)
|
Author keywords
diabetes mellitus; DPP IV; glimepiride; islet cell function
|
Indexed keywords
ANTIDIABETIC AGENT;
BIOLOGICAL MARKER;
GLIMEPIRIDE;
GLUCAGON;
GLUCAGON LIKE PEPTIDE 1;
GLUCOSE BLOOD LEVEL;
INSULIN;
LINAGLIPTIN;
METFORMIN;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PROINSULIN;
PURINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
SULFONYLUREA DERIVATIVE;
AGED;
BLOOD;
CARDIOVASCULAR DISEASES;
COMPLICATION;
CONTROLLED STUDY;
DIABETES MELLITUS, TYPE 2;
DRUG COMBINATION;
DRUG EFFECTS;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
PANCREAS ISLET;
PHYSIOLOGY;
POSTPRANDIAL STATE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
AGED;
BIOLOGICAL MARKERS;
BLOOD GLUCOSE;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
DRUG THERAPY, COMBINATION;
FEMALE;
GLUCAGON;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
ISLETS OF LANGERHANS;
MALE;
METFORMIN;
MIDDLE AGED;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
POSTPRANDIAL PERIOD;
PROINSULIN;
PURINES;
QUINAZOLINES;
RISK FACTORS;
SULFONYLUREA COMPOUNDS;
|
EID: 84900998054
PISSN: None
EISSN: 15207560
Source Type: Journal
DOI: 10.1002/dmrr.2525 Document Type: Article |
Times cited : (25)
|
References (0)
|